Covetrus reports 11% sales growth in Q3 results

Covetrus Inc. (Nasdaq: CVET), the Portland-based animal-health company, reported sales were up 11% during the third quarter compared to the same period last year, driven by customer demand that reached pre-pandemic levels in some markets.

Net sales from July to September were $1.13 billion, about $80 million more than analysts’ consensus expectations, and an increase from $1.02 billion for Q3 in 2019. The jump reflected “companion animal end-market growth that returned to pre-COVID-19 levels across many of the company’s major geographies” among other factors, Covetrus said in a news release late Tuesday. Read more

Related Posts

UNE undergraduate receives BioME grant to study rare lobster larvae

A University of New England undergraduate student has received a $5,000 grant from the Bioscience Association of Maine (BioME) to fund...

23 May 2024

New initiative unites Maine’s innovators to bolster STEM research and workforce

An $8 million grant from the National Science Foundation will fund a four-year initiative led by the University of Maine to bolster STEM...

15 May 2024

Jackson Lab hires its first-ever chief scientific officer

Jackson Laboratory, based in Bar Harbor, has hired Mary Dickinson, a globally recognized geneticist, developmental biologist, and bioengineer, as executive vice...

13 May 2024